ArticleMolecular cancer therapeutics2021

PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus.

Gabriel B Mpilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.